LymphedemaV1, PubMed, Curation, bibRecord, 000A18

Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.

Identifieur interne : 000A18 ( PubMed/Curation ); précédent : 000A17; suivant : 000A19

Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.

Auteurs : Marcus Lanza [Brésil] ; Anke Bergmann [Brésil] ; Maria Giseli Da Costa Leite Ferreira [Brésil] ; Suzana Sales De Aguiar [Brésil] ; Ricardo De Almeida Dias [Brésil] ; Karen De Souza Abrahão [Brésil] ; Ester M. Paltrinieri [Argentine] ; Ruy G Martínez Allende [Argentine] ; Mauro Figueiredo Carvalho De Andrade [Brésil]

Source :

International journal of breast cancer [ 2090-3170 ] ; 2015.

RBID : pubmed:26843988

Abstract

Purpose. To assess the quality of life (QOL) as a predictor of volume reduction in women undergoing complex physical therapy (CPT) for lymphoedema following breast cancer. Methods. Clinical trial in 57 women undergoing CPT. Results. At baseline, in measuring quality of life for the EORTC QLQ-C30 questionnaire subscale of functionality, the worst scores for emotional function (55 points) and better social function (89 points) were observed. The symptom scales showed the worst pain averaged (66 points). The overall quality of life showed a low score (40 points). In the BR 23 module, low scores were observed in the field of future perspective (47 points). After treatment of lymphoedema, absolute reduction of excess volume between the upper limbs of 282 mL was observed, representing a reduction of 15%. No association was observed between the domains of quality of life and response to treatment of lymphoedema. Conclusion. This study included 57 women with advanced and chronic lymphoedema in early treatment with CPT and low scores for quality of life. The lymphoedema therapeutic response was not influenced by the QOL at the beginning of treatment.

DOI: 10.1155/2015/586827
PubMed: 26843988

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A18

Links to Exploration step

pubmed:26843988

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.</title>
<author><name sortKey="Lanza, Marcus" sort="Lanza, Marcus" uniqKey="Lanza M" first="Marcus" last="Lanza">Marcus Lanza</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro Universitário Augusto Motta, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Centro Universitário Augusto Motta, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bergmann, Anke" sort="Bergmann, Anke" uniqKey="Bergmann A" first="Anke" last="Bergmann">Anke Bergmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ferreira, Maria Giseli Da Costa Leite" sort="Ferreira, Maria Giseli Da Costa Leite" uniqKey="Ferreira M" first="Maria Giseli Da Costa Leite" last="Ferreira">Maria Giseli Da Costa Leite Ferreira</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Aguiar, Suzana Sales" sort="De Aguiar, Suzana Sales" uniqKey="De Aguiar S" first="Suzana Sales" last="De Aguiar">Suzana Sales De Aguiar</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dias, Ricardo De Almeida" sort="Dias, Ricardo De Almeida" uniqKey="Dias R" first="Ricardo De Almeida" last="Dias">Ricardo De Almeida Dias</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Abrahao, Karen De Souza" sort="Abrahao, Karen De Souza" uniqKey="Abrahao K" first="Karen De Souza" last="Abrahão">Karen De Souza Abrahão</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Paltrinieri, Ester M" sort="Paltrinieri, Ester M" uniqKey="Paltrinieri E" first="Ester M" last="Paltrinieri">Ester M. Paltrinieri</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro Vodder Argentina, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Centro Vodder Argentina, Buenos Aires</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Allende, Ruy G Martinez" sort="Allende, Ruy G Martinez" uniqKey="Allende R" first="Ruy G Martínez" last="Allende">Ruy G Martínez Allende</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro Vodder Argentina, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Centro Vodder Argentina, Buenos Aires</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Andrade, Mauro Figueiredo Carvalho" sort="De Andrade, Mauro Figueiredo Carvalho" uniqKey="De Andrade M" first="Mauro Figueiredo Carvalho" last="De Andrade">Mauro Figueiredo Carvalho De Andrade</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Faculdade de Medicina da Universidade de São Paulo, São Paulo</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26843988</idno>
<idno type="pmid">26843988</idno>
<idno type="doi">10.1155/2015/586827</idno>
<idno type="wicri:Area/PubMed/Corpus">000A18</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A18</idno>
<idno type="wicri:Area/PubMed/Curation">000A18</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A18</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.</title>
<author><name sortKey="Lanza, Marcus" sort="Lanza, Marcus" uniqKey="Lanza M" first="Marcus" last="Lanza">Marcus Lanza</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro Universitário Augusto Motta, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Centro Universitário Augusto Motta, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bergmann, Anke" sort="Bergmann, Anke" uniqKey="Bergmann A" first="Anke" last="Bergmann">Anke Bergmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ferreira, Maria Giseli Da Costa Leite" sort="Ferreira, Maria Giseli Da Costa Leite" uniqKey="Ferreira M" first="Maria Giseli Da Costa Leite" last="Ferreira">Maria Giseli Da Costa Leite Ferreira</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Aguiar, Suzana Sales" sort="De Aguiar, Suzana Sales" uniqKey="De Aguiar S" first="Suzana Sales" last="De Aguiar">Suzana Sales De Aguiar</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dias, Ricardo De Almeida" sort="Dias, Ricardo De Almeida" uniqKey="Dias R" first="Ricardo De Almeida" last="Dias">Ricardo De Almeida Dias</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Abrahao, Karen De Souza" sort="Abrahao, Karen De Souza" uniqKey="Abrahao K" first="Karen De Souza" last="Abrahão">Karen De Souza Abrahão</name>
<affiliation wicri:level="1"><nlm:affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Instituto Nacional de Câncer, Rio de Janeiro</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Paltrinieri, Ester M" sort="Paltrinieri, Ester M" uniqKey="Paltrinieri E" first="Ester M" last="Paltrinieri">Ester M. Paltrinieri</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro Vodder Argentina, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Centro Vodder Argentina, Buenos Aires</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Allende, Ruy G Martinez" sort="Allende, Ruy G Martinez" uniqKey="Allende R" first="Ruy G Martínez" last="Allende">Ruy G Martínez Allende</name>
<affiliation wicri:level="1"><nlm:affiliation>Centro Vodder Argentina, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Centro Vodder Argentina, Buenos Aires</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Andrade, Mauro Figueiredo Carvalho" sort="De Andrade, Mauro Figueiredo Carvalho" uniqKey="De Andrade M" first="Mauro Figueiredo Carvalho" last="De Andrade">Mauro Figueiredo Carvalho De Andrade</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Faculdade de Medicina da Universidade de São Paulo, São Paulo</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of breast cancer</title>
<idno type="ISSN">2090-3170</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose. To assess the quality of life (QOL) as a predictor of volume reduction in women undergoing complex physical therapy (CPT) for lymphoedema following breast cancer. Methods. Clinical trial in 57 women undergoing CPT. Results. At baseline, in measuring quality of life for the EORTC QLQ-C30 questionnaire subscale of functionality, the worst scores for emotional function (55 points) and better social function (89 points) were observed. The symptom scales showed the worst pain averaged (66 points). The overall quality of life showed a low score (40 points). In the BR 23 module, low scores were observed in the field of future perspective (47 points). After treatment of lymphoedema, absolute reduction of excess volume between the upper limbs of 282 mL was observed, representing a reduction of 15%. No association was observed between the domains of quality of life and response to treatment of lymphoedema. Conclusion. This study included 57 women with advanced and chronic lymphoedema in early treatment with CPT and low scores for quality of life. The lymphoedema therapeutic response was not influenced by the QOL at the beginning of treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26843988</PMID>
<DateCreated><Year>2016</Year>
<Month>02</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>02</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2090-3170</ISSN>
<JournalIssue CitedMedium="Print"><Volume>2015</Volume>
<PubDate><Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>International journal of breast cancer</Title>
<ISOAbbreviation>Int J Breast Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.</ArticleTitle>
<Pagination><MedlinePgn>586827</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1155/2015/586827</ELocationID>
<Abstract><AbstractText>Purpose. To assess the quality of life (QOL) as a predictor of volume reduction in women undergoing complex physical therapy (CPT) for lymphoedema following breast cancer. Methods. Clinical trial in 57 women undergoing CPT. Results. At baseline, in measuring quality of life for the EORTC QLQ-C30 questionnaire subscale of functionality, the worst scores for emotional function (55 points) and better social function (89 points) were observed. The symptom scales showed the worst pain averaged (66 points). The overall quality of life showed a low score (40 points). In the BR 23 module, low scores were observed in the field of future perspective (47 points). After treatment of lymphoedema, absolute reduction of excess volume between the upper limbs of 282 mL was observed, representing a reduction of 15%. No association was observed between the domains of quality of life and response to treatment of lymphoedema. Conclusion. This study included 57 women with advanced and chronic lymphoedema in early treatment with CPT and low scores for quality of life. The lymphoedema therapeutic response was not influenced by the QOL at the beginning of treatment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lanza</LastName>
<ForeName>Marcus</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Centro Universitário Augusto Motta, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bergmann</LastName>
<ForeName>Anke</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ferreira</LastName>
<ForeName>Maria Giseli da Costa Leite</ForeName>
<Initials>MG</Initials>
<AffiliationInfo><Affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>de Aguiar</LastName>
<ForeName>Suzana Sales</ForeName>
<Initials>SS</Initials>
<AffiliationInfo><Affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dias</LastName>
<ForeName>Ricardo de Almeida</ForeName>
<Initials>Rde A</Initials>
<AffiliationInfo><Affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Abrahão</LastName>
<ForeName>Karen de Souza</ForeName>
<Initials>Kde S</Initials>
<AffiliationInfo><Affiliation>Instituto Nacional de Câncer, Rio de Janeiro, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Paltrinieri</LastName>
<ForeName>Ester M</ForeName>
<Initials>EM</Initials>
<AffiliationInfo><Affiliation>Centro Vodder Argentina, Buenos Aires, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Allende</LastName>
<ForeName>Ruy G Martínez</ForeName>
<Initials>RG</Initials>
<AffiliationInfo><Affiliation>Centro Vodder Argentina, Buenos Aires, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>de Andrade</LastName>
<ForeName>Mauro Figueiredo Carvalho</ForeName>
<Initials>MF</Initials>
<AffiliationInfo><Affiliation>Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>12</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Egypt</Country>
<MedlineTA>Int J Breast Cancer</MedlineTA>
<NlmUniqueID>101568103</NlmUniqueID>
<ISSNLinking>2090-3189</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2007 Jun;14(6):1904-8</RefSource>
<PMID Version="1">17342565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2013 Oct 20;31(30):3758-63</RefSource>
<PMID Version="1">24043733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011 Sep 01;343:d5326</RefSource>
<PMID Version="1">21885537</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Feb;131(3):987-92</RefSource>
<PMID Version="1">21987036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2014 Dec;92(3):227-34</RefSource>
<PMID Version="1">25085806</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2013 Mar;46(1):1-11</RefSource>
<PMID Version="1">23930436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Aug;19(8):2580-9</RefSource>
<PMID Version="1">22395997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2014 Jun;47(2):82-91</RefSource>
<PMID Version="1">25282874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2012 Sep;10(3):129-35</RefSource>
<PMID Version="1">22984910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2008 Jun 1;97(7):572-7</RefSource>
<PMID Version="1">18459131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2011 Jul;19(7):935-40</RefSource>
<PMID Version="1">20495983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2013 Mar;22(2):283-94</RefSource>
<PMID Version="1">22419450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2010 Aug;19(6):789-802</RefSource>
<PMID Version="1">20340047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2005 Sep;93(1):49-54</RefSource>
<PMID Version="1">16184458</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2013 Feb;22(1):1-11</RefSource>
<PMID Version="1">22383104</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Rehabil. 2012 Jul;26(7):607-18</RefSource>
<PMID Version="1">22172923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2014 Oct;23(8):2327-32</RefSource>
<PMID Version="1">24706337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2004 Jul;86(2):95-106</RefSource>
<PMID Version="1">15319562</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2011 Nov-Dec;17(6):571-8</RefSource>
<PMID Version="1">21895846</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2013 Jan-Feb;19(1):114-5</RefSource>
<PMID Version="1">23241012</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):841-6</RefSource>
<PMID Version="1">17175115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2014 Jul-Aug;20(4):420-2</RefSource>
<PMID Version="1">24943048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast. 2012 Jun;21(3):321-5</RefSource>
<PMID Version="1">22377590</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2011 Nov-Dec;17(6):569-70</RefSource>
<PMID Version="1">22050280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2014 Mar;23(2):627-37</RefSource>
<PMID Version="1">23873516</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2010 Nov-Dec;16(6):587-97</RefSource>
<PMID Version="1">21070435</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2009 Dec;18(10):1321-9</RefSource>
<PMID Version="1">19862640</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4710936</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>07</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>11</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26843988</ArticleId>
<ArticleId IdType="doi">10.1155/2015/586827</ArticleId>
<ArticleId IdType="pmc">PMC4710936</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A18 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000A18 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26843988
   |texte=   Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:26843988" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.

Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki